SCHEMBL6409654

SCHEMBL6409654

COc1ccc(C(OCC2C(C)C2C(=O)OC2CCCCC2)(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A11 P48066 7/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
SLC6A12 P48065 2/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
SLC6A13 Q9NSD5 1/20 0.41
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
SLC6A1 P30531 3/20 0.40
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
RAB9A P51151 1/20 0.38
MDM2 Q00987 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SLC6A2 P23975 1/20 0.37
FABP7 O15540 1/20 0.37
FABP5 Q01469 1/20 0.37
EPHX2 P34913 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6407574 0.96 SLC6A11 (0.45) SLC6A11MEN1KMT2ASLC6A12TP53
SCHEMBL6408948 0.96 SLC6A11 (0.45) SLC6A11MEN1KMT2ASLC6A12TP53
SCHEMBL6407153 0.87 FABP7 (0.47) SLC6A4SLC6A3SLC6A1FABP7FABP5
SCHEMBL6407666 0.83 SMN1; SMN2 (0.43) SLC6A11MEN1KMT2ASLC6A12TP53
SCHEMBL6411945 0.81 CACNA1B (0.43) KMT2ACYP1A2CYP3A4SLC6A4SLC6A3
SCHEMBL6480399 0.80 ALDH1A1 (0.38) SLC6A11MEN1KMT2ASLC6A12TP53
SCHEMBL6412660 0.80 SLC6A11 (0.41) SLC6A11MEN1KMT2ASLC6A12TP53
SCHEMBL6408753 0.80 SLC6A11 (0.45) SLC6A11MEN1KMT2ASLC6A12TP53
SCHEMBL6410799 0.79 SLC6A11 (0.43) SLC6A11MEN1KMT2ASLC6A12TP53
SCHEMBL6481384 0.79 SLC6A11 (0.43) SLC6A11MEN1KMT2ASLC6A12TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids SUMITOMO CHEMICAL COMPAY LIMTED (JP) 2005-12-29 US disclosed
EP-1538141-A1 PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids GRHPR, PCCA, C5 SLC6A11 2935/4885MEN1 333/4885KMT2A 586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.